Loading clinical trials...
Loading clinical trials...
Purpose of the study is to evaluate the effectiveness and safety of a new investigational dur, IC351. Study is designed to gather information regarding the possible usefulness of IC351 as a treatment ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Medicine and Dentistry of New Jersey
NCT06733935 · Systemic Sclerosis, Idiopathic Inflammatory Myopathies, and more
NCT06308978 · Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), and more
NCT05869955 · Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathy, and more
NCT07558850 · Rheumatoid Arthritis, Dermatomyositis, and more
NCT06655155 · Systemic Sclerosis (SSc)
UMDNJ
New Brunswick, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions